We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
+3.97%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$19.2B
AUM Growth
+$125M
Cap. Flow
-$574M
Cap. Flow %
-2.99%
Top 10 Hldgs %
51.61%
Holding
25
New
–
Increased
1
Reduced
24
Closed
–

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$93.2M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$203M
2
GWW icon
W.W. Grainger
GWW
+$166M
3
DG icon
Dollar General
DG
+$57M
4
TMO icon
Thermo Fisher Scientific
TMO
+$40.5M
5
TMX
Terminix Global Holdings, Inc.
TMX
+$26.1M

Sector Composition

Rank Sector Weight
1 Healthcare 37.84%
2 Financials 23.34%
3 Industrials 16.59%
4 Technology 13.07%
5 Consumer Staples 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWW icon
1
W.W. Grainger
GWW
$64.5B
$1.09B 5.68%
3,534,534
-555,365
-14% -$166M
FIS icon
2
Fidelity National Information Services
FIS
$23.9B
$1.07B 5.56%
10,062,755
-150,247
-1% -$15.3M
HSIC icon
3
Henry Schein
HSIC
$9.72B
$1.01B 5.24%
17,651,676
-55,491
-0.3% -$3.13M
UNH icon
4
UnitedHealth
UNH
$385B
$999M 5.2%
4,072,098
-56,812
-1% -$13.6M
HCA icon
5
HCA Healthcare
HCA
$91.8B
$979M 5.1%
9,542,360
-123,602
-1% -$12.5M
DG icon
6
Dollar General
DG
$28.3B
$978M 5.09%
9,921,543
-593,121
-6% -$57M
IQV icon
7
IQVIA
IQV
$40.4B
$967M 5.03%
9,683,965
-105,655
-1% -$10.6M
BNY
8
Bank of New York Mellon
BNY
$104B
$952M 4.96%
17,649,013
-171,771
-1% -$9.48M
EMR icon
9
Emerson Electric
EMR
$81.7B
$940M 4.9%
13,598,373
-145,712
-1% -$10.2M
WFC icon
10
Wells Fargo
WFC
$257B
$932M 4.86%
16,817,682
-151,045
-0.9% -$8.09M
WTW icon
11
Willis Towers Watson
WTW
$30.1B
$930M 4.84%
6,131,312
-59,420
-1% -$9.04M
PFE icon
12
Pfizer
PFE
$144B
$926M 4.82%
26,897,431
-290,502
-1% -$9.93M
AON icon
13
Aon
AON
$80.4B
$926M 4.82%
6,748,667
-172,930
-2% -$24.4M
ORCL icon
14
Oracle
ORCL
$339B
$866M 4.51%
19,653,249
-212,062
-1% -$9.77M
ZBH icon
15
Zimmer Biomet
ZBH
$18.7B
$864M 4.5%
7,981,361
-96,017
-1% -$10.5M
STT icon
16
State Street
STT
$48.9B
$742M 3.87%
7,972,455
-80,216
-1% -$7.95M
TMO icon
17
Thermo Fisher Scientific
TMO
$213B
$667M 3.47%
3,219,655
-190,875
-6% -$40.5M
PH icon
18
Parker-Hannifin
PH
$119B
$627M 3.27%
4,023,212
-35,185
-0.9% -$6M
MDT icon
19
Medtronic
MDT
$113B
$596M 3.11%
6,965,895
-63,585
-0.9% -$5.31M
TMX
20
DELISTED
Terminix Global Holdings, Inc.
TMX
$528M 2.75%
13,264,639
-703,411
-5% -$26.1M
OMC icon
21
Omnicom Group
OMC
$23.7B
$491M 2.56%
6,436,593
-60,496
-0.9% -$4.47M
FISV
22
Fiserv Inc
FISV
$29.7B
$359M 1.87%
4,846,334
-2,791,258
-37% -$203M
TJX icon
23
TJX Companies
TJX
$180B
$290M 1.51%
6,100,956
-62,878
-1% -$2.76M
AGN
24
DELISTED
Allergan plc
AGN
$262M 1.36%
1,570,931
+580,808
+59% +$93.2M
ARW icon
25
Arrow Electronics
ARW
$10.4B
$218M 1.14%
2,896,179
-26,312
-0.9% -$2M

Similar funds

NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RPI
Railway Pension Investments London, United Kingdom $7.03B AUM 18.92% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
CWM
Circle Wealth Management Summit, New Jersey $7.02B AUM 19.32% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $6.98B AUM
DE
Defiance ETFs New York $6.98B AUM
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Longview Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Longview Partners held 25 positions worth $19.2B, up 0.65% from $19.1B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 0%. Longview Partners opened no new positions and made no exits, leaving the 25-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 36% a quarter earlier, followed by Financials and Industrials.

  • Longview Partners added most to Allergan plc in Q2 2018, an estimated $93.2M increase.
  • Longview Partners's biggest Q2 2018 reduction was Fiserv Inc, cutting an estimated $203M.
  • Longview Partners's ten largest holdings make up 52% of its $19.2B portfolio in Q2 2018.
  • Longview Partners opened 0 new positions and closed 0 in Q2 2018.
  • Longview Partners's portfolio value rose 0.65% quarter-over-quarter to $19.2B.

Based on Longview Partners's 13F filing for Q2 2018, filed 1 Aug 2018.